Cited by 5,228Liver Disease Diagnosis and TreatmentAlcohol Consumption and Health EffectsLiver physiology and pathology

The DOI matches its Crossref record; 90 of the 92 references it cites were found in a registry or an index, and 2 are not checked yet.

Nonalcoholic Fatty Liver Disease

Angulo, Paul·2002·New England Journal of Medicine

DOI 10.1056/nejmra011775

Open this paper in CoChat — free account

Abstract

Alcohol abuse is the most common cause of fatty liver disease, but it is now apparent that fat deposition in the liver, and its consequences, may occur without alcohol abuse. The principal risk factors are obesity, non-insulin-dependent diabetes mellitus, and hyperlipidemia. The disorder has a wide clinical spectrum, ranging from asymptomatic steatosis to steatohepatitis, fibrosis, and cirrhosis. This article provides a broad overview of this increasingly recognized liver disease.

Integrity signals

Registry

Crossref · 10.1056/nejmra011775

Cites

90 of 92 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01377.x · Cited by 3,907
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
Overweight and obesity in the United States: prevalence and trends, 1960–1994
Flegal, K., Carroll, M., Kuczmarski, R., & Johnson, C. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800541 · Cited by 3,045
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
Alter, M. J., Kruszon‐Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., Kaslow, R. A., & Margolis, H. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410802 · Cited by 2,973
Nonalcoholic Steatohepatitis
Ludwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988–1994
Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703
IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078

Show all 90 references

Research works printed but not linked: 9

Schaffner F, 1986, Prog Liver Dis, 8, 283
Itoh S, 1987, Am J Gastroenterol, 82, 650
Silverman JF, 1990, Am J Gastroenterol, 85, 1349
Creutzfeldt W, 1970, Prog Liver Dis, 3, 371
Silverman JF, 1989, Pathol Annu, 24, 275
Debaere C, 1998, J Belge Radiol, 81, 174
Zatloukal K, 1991, Lab Invest, 64, 200
Curzio M, 1985, Int J Tissue React, 7, 137
Watson AM, 1999, Drug Metab Dispos, 27, 695

Sorted by citations

Items 601–700 of 1,031

Defining nonalcoholic fatty liver disease: Implications for epidemiologic studies
Clark, J. M., & Diehl, A. M. (2003) · Gastroenterology · doi:10.1053/gast.2003.50032 · Cited by 166
Fatty acids promote fatty liver disease via the dysregulation of 3-mercaptopyruvate sulfurtransferase/hydrogen sulfide pathway
Li, M., Xu, C., Shi, J., Ding, J., Wan, X., Chen, D., Gao, J., Li, C., Zhang, J., Lin, Y., et al. (2017) · Gut · doi:10.1136/gutjnl-2017-313778 · Cited by 165
Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification
Lee, D. H. (2017) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2017.0042 · Cited by 165
Reduction of Hepatosteatosis and Lipid Levels by an Adipose Differentiation-Related Protein Antisense Oligonucleotide
Imai, Y., Varela, G. M., Jackson, M. B., Graham, M. J., Crooke, R. M., & Ahima, R. S. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.02.046 · Cited by 165
Leptin and the Control of Metabolism: Role for Stearoyl-CoA Desaturase-1 (SCD-1)
Cohen, P., & Friedman, J. M. (2004) · Journal of Nutrition · doi:10.1093/jn/134.9.2455s · Cited by 165
Hypothalamic Leptin Signaling Regulates Hepatic Insulin Sensitivity via a Neurocircuit Involving the Vagus Nerve
German, J., Kim, F., Schwartz, G. J., Havel, P. J., Rhodes, C. J., Schwartz, M. W., & Morton, G. J. (2009) · Endocrinology · doi:10.1210/en.2009-0445 · Cited by 164
High Serum Uric Acid Increases the Risk for Nonalcoholic Fatty Liver Disease: A Prospective Observational Study
Xu, C., Yu, C., Xu, L., Miao, M., & Li, Y. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011578 · Cited by 164
Infliximab reverses steatosis and improves insulin signal transduction in liver of rats fed a high-fat diet
Barbuio, R., Milanski, M., Bértolo, M. B., Saad, M. J. A., & Velloso, L. A. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0234 · Cited by 164
Ezetimibe improves liver steatosis and insulin resistance in obese rat model of metabolic syndrome
Deushi, M., Nomura, M., Kawakami, A., Haraguchi, M., Ito, M., Okazaki, M., Ishii, H., & Yoshida, M. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.11.023 · Cited by 164
Pathophysiology of NASH: perspectives for a targeted treatment
Marra, F., & Lotersztajn, S. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990344 · Cited by 163
Functional foods as potential therapeutic options for metabolic syndrome
Brown, L., Poudyal, H., & Panchal, S. K. (2015) · Obesity Reviews · doi:10.1111/obr.12313 · Cited by 163
Prevalence of and risk factors for non-alcoholic fatty liver disease in a non-obese Japanese population, 2011–2012
Nishioji, K., Sumida, Y., Kamaguchi, M., Mochizuki, N., Kobayashi, M., Nishimura, T., Yamaguchi, K., & Itoh, Y. (2014) · Journal of Gastroenterology · doi:10.1007/s00535-014-0948-9 · Cited by 163
Glucose dysregulation and hepatic steatosis in obese adolescents
Cali, A. M. G., de Oliveira, A. M., Kim, H.-J., Chen, S., Reyes‐Múgica, M., Escalera, S., Dziura, J., Taksali, S. E., Kursawe, R., Shaw, M. M., et al. (2009) · Hepatology · doi:10.1002/hep.22858 · Cited by 163
Nonalcoholic Steatohepatitis
Suzuki, A., & Diehl, A. M. (2016) · Annual Review of Medicine · doi:10.1146/annurev-med-051215-031109 · Cited by 163
Review article: the iron overload syndromes
Siddique, A., & Kowdley, K. V. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05051.x · Cited by 162
Caspase 3 Inactivation Protects Against Hepatic Cell Death and Ameliorates Fibrogenesis in a Diet-Induced NASH Model
Thapaliya, S., Wree, A., Povero, D., Inzaugarat, M. E., Berk, M., Dixon, L., Papouchado, B. G., & Feldstein, A. E. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3167-6 · Cited by 162
Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections
Bassetti, M., Repetto, E. C., Righi, E., Boni, S., Diverio, M., Molinari, M. P., Mussap, M., Artioli, S., Ansaldi, F., Durando, P., et al. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm509 · Cited by 162
Severe Steatosis Increases Hepatocellular Injury and Impairs Liver Regeneration in a Rat Model of Partial Hepatectomy
inen, R. V., van Vliet, A. K., & van Gulik, T. M. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000225253.84501.0e · Cited by 162
Nonalcoholic steatohepatitis and increased risk of chronic kidney disease
Yasui, K., Sumida, Y., Mori, Y., Mitsuyoshi, H., Minami, M., Itoh, Y., Kanemasa, K., Matsubara, H., Okanoue, T., & Yoshikawa, T. (2010) · Metabolism · doi:10.1016/j.metabol.2010.07.022 · Cited by 161
Fatty liver in familial hypobetalipoproteinemia
Tanoli, T., Yue, P., Yablonskiy, D. A., & Schonfeld, G. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300508-jlr200 · Cited by 161
Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016
Kaswala, D. H., Lai, M., & Afdhal, N. H. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4079-4 · Cited by 161
Hepatorenal Index as an Accurate, Simple, and Effective Tool in Screening for Steatosis
Marshall, R. H., Eissa, M., Bluth, E. I., Gulotta, P. M., & Davis, N. K. (2012) · American Journal of Roentgenology · doi:10.2214/ajr.11.6677 · Cited by 160
Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis
Serfaty, L., & Lemoine, M. (2008) · Diabetes & Metabolism · doi:10.1016/s1262-3636(08)74597-x · Cited by 160
The B-Mode Image-Guided Ultrasound Attenuation Parameter Accurately Detects Hepatic Steatosis in Chronic Liver Disease
Fujiwara, Y., Kuroda, H., Abe, T., Ishida, K., Oguri, T., Noguchi, S., Sugai, T., Kamiyama, N., & Takikawa, Y. (2018) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2018.06.017 · Cited by 160
Resveratrol alleviates non-alcoholic fatty liver disease through epigenetic modification of the Nrf2 signaling pathway
Hosseini, H., Teimouri, M., Shabani, M., Koushki, M., Khorzoughi, R. B., Namvarjah, F., Izadi, P., & Meshkani, R. (2019) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2019.105667 · Cited by 160
Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis
Dixon, L. J., Berk, M. P., Thapaliya, S., Papouchado, B. G., & Feldstein, A. E. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.45 · Cited by 159
Antidiabetic effect of total saponins from Entada phaseoloides (L.) Merr. in type 2 diabetic rats
Zheng, T., Shu, G., Yang, Z., Mo, S., Zhao, Y., & Mei, Z. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.12.025 · Cited by 159
CCAAT/enhancing binding protein β deletion in mice attenuates inflammation, endoplasmic reticulum stress, and lipid accumulation in diet‐induced nonalcoholic steatohepatitis†
Rahman, S. M., Schroeder‐Gloeckler, J. M., Janssen, R. C., Jiang, H., Qadri, I., Maclean, K. N., & Friedman, J. E. (2007) · Hepatology · doi:10.1002/hep.21614 · Cited by 159
Liver diseases and metabolic syndrome
Watanabe, S., Yaginuma, R., Ikejima, K., & Miyazaki, A. (2008) · Journal of Gastroenterology · doi:10.1007/s00535-008-2193-6 · Cited by 158
Liver transplantation and non-alcoholic fatty liver disease
Zezos, P. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i42.15532 · Cited by 158
The Forkhead Transcription Factor FoxO1 Regulates Proliferation and Transdifferentiation of Hepatic Stellate Cells
Adachi, M., Osawa, Y., Uchinami, H., Kitamura, T., Accili, D., & Brenner, D. A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.01.033 · Cited by 158
Effect of High-Dose Vitamin E on Insulin Resistance and Associated Parameters in Overweight Subjects
Manning, P. J., Sutherland, W. H. F., Walker, R. J., Williams, S., de Jong, S. A., Ryalls, A. R., & Berry, E. A. (2004) · Diabetes Care · doi:10.2337/diacare.27.9.2166 · Cited by 158
Berberine reduces methylation of the MTTP promoter and alleviates fatty liver induced by a high-fat diet in rats
Chang, X., Yan, H., Jing, F., Jiang, M., Zhu, H., Lu, D., & Gao, X. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m001958 · Cited by 157
Nonalcoholic fatty liver disease: Definitions, risk factors, and workup
Puri, P., & Sanyal, A. J. (2012) · Clinical Liver Disease · doi:10.1002/cld.81 · Cited by 156
Non–Laboratory-Based Self-Assessment Screening Score for Non-Alcoholic Fatty Liver Disease: Development, Validation and Comparison with Other Scores
Lee, Y., Bang, H., Park, Y. M., Bae, J. C., Lee, B., Kang, E. S., Soo, B., Lee, H. C., Balkau, B., Lee, W., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107584 · Cited by 156
Dietary n-3 polyunsaturated fatty acids decrease hepatic triglycerides in Fischer 344 rats
Levy, J. R., Clore, J. N., & Stevens, W. D. (2004) · Hepatology · doi:10.1002/hep.20093 · Cited by 156
5-Lipoxygenase Activating Protein Signals Adipose Tissue Inflammation and Lipid Dysfunction in Experimental Obesity
Horrillo, R., González‐Périz, A., Martínez‐Clemente, M., López‐Parra, M., Ferré, N., Titos, E., Morán‐Salvador, E., Deulofeu, R., Arroyo, V., & Clària, J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901355 · Cited by 156
PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty‐acid metabolic enzymes
Seo, Y. S., Kim, J. H., Jo, N. Y., Choi, K. M., Baik, S. H., Park, J., Kim, J. J., Byun, K. S., Bak, Y., Lee, C. H., et al. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04819.x · Cited by 155
Association Between Patatin-Like Phospholipase Domain Containing 3 Gene (PNPLA3) Polymorphisms and Nonalcoholic Fatty Liver Disease: A HuGE Review and Meta-Analysis
Xu, R., Tao, A., Zhang, S., Deng, Y., & Chen, G. (2015) · Scientific Reports · doi:10.1038/srep09284 · Cited by 155
Is obesity a risk factor in acute pancreatitis? A meta-analysis
Martínez, J., Sánchez–Payá, J., Palazón, J. M., Suazo-Barahona, J., Robles‐Díaz, G., & Pérez‐Mateo, M. (2004) · Pancreatology · doi:10.1159/000077025 · Cited by 155
Posttransplant Metabolic Syndrome
Pagadala, M. R., Dasarathy, S., Eghtesad, B., & McCullough, A. J. (2009) · Liver Transplantation · doi:10.1002/lt.21952 · Cited by 155
A low level of serum total testosterone is independently associated with nonalcoholic fatty liver disease
Kim, S., Kwon, H., Park, J., Cho, B., Kim, D., Oh, S., Lee, C. M., & Choi, H.-C. (2012) · BMC Gastroenterology · doi:10.1186/1471-230x-12-69 · Cited by 155
Epidemiology of paediatric metabolic syndrome and type 2 diabetes mellitus
de Ferranti, S. D., & Osganian, S. K. (2007) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2007.055 · Cited by 155
Prevalence of liver steatosis in patients with chronic hepatitis B: a study of associated factors and of relationship with fibrosis
Thomopoulos, K. C., Arvaniti, V., Tsamantas, A. C., Dimitropoulou, D., Gogos, C. A., Siagris, D., Theocharis, G. J., & Labropoulou‐Karatza, C. (2006) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200603000-00002 · Cited by 155
Pediatric non-alcoholic fatty liver disease: an increasing public health issue
Berardis, S., & Sokal, E. M. (2013) · European Journal of Pediatrics · doi:10.1007/s00431-013-2157-6 · Cited by 154
Standardized Ultrasound Hepatic/Renal Ratio and Hepatic Attenuation Rate to Quantify Liver Fat Content: An Improvement Method
Xia, M., Yan, H., He, W., Li, X., Li, C., Yao, X., Li, R., Zeng, M., & Gao, X. (2011) · Obesity · doi:10.1038/oby.2011.302 · Cited by 154
Hepatic steatosis and insulin resistance: Does etiology make a difference?
Lonardo, A., Lombardini, S., Scaglioni, F., Carulli, L., Ricchi, M., Ganazzi, D., Adinolfi, L. E., Ruggiero, G., Carulli, N., & Loria, P. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.06.018 · Cited by 154
Resistin as an Intrahepatic Cytokine
Bertolani, C., Sancho‐Bru, P., Failli, P., Bataller, R. A., Aleffi, S., DeFranco, R., Mazzinghi, B., Romagnani, P., Milani, S., Ginès, P., et al. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.060081 · Cited by 153
Serum adipokine levels predictive of liver injury in non‐alcoholic fatty liver disease
Lemoine, M., Ratziu, V., Kim, M. J., Maachi, M., Wendum, D., Paye, F., Bastard, J. P., Poupon, R. Y., Housset, C., Capeau, J., et al. (2009) · Liver International · doi:10.1111/j.1478-3231.2009.02022.x · Cited by 153
Overweight and obesity, hepatic steatosis, and progression of chronic hepatitis C: a retrospective study on a large cohort of patients in the United States
Hu, K., Kyulo, N. L., Esrailian, E., Thompson, K., Chase, R., Hillebrand, D. J., & Runyon, B. A. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00479-3 · Cited by 153
Role of peroxisome proliferators-activated receptors in the pathogenesis and treatment of nonalcoholic fatty liver disease
Kallwitz, E. R., McLachlan, A., & Cotler, S. J. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.22 · Cited by 152
Long-term baicalin administration ameliorates metabolic disorders and hepatic steatosis in rats given a high-fat diet
Guo, H., Liu, D.-H., Ma, Y., Liu, J.-F., Wang, Y., Du, Z., Wang, X., Shen, J., & Peng, H. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.150 · Cited by 152
Regulation of fat metabolism in the liver: link to non-alcoholic hepatic steatosis and impact of physical exercise
Lavoie, J.-M., & Gauthier, M. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6600-y · Cited by 152
Branched-chain amino acid catabolism is a conserved regulator of physiological ageing
Mansfeld, J., Urban, N., Priebe, S., Groth, M., Frahm, C., Hartmann, N., Gebauer, J., Ravichandran, M., Dommaschk, A., Schmeisser, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms10043 · Cited by 151
Glucocorticoid-Induced Fatty Liver Disease
Rahimi, L., Rajpal, A., & Ismail‐Beigi, F. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s247379 · Cited by 151
Non‐alcoholic steatohepatitis in the Asia–Pacific region: Future shock?
Chitturi, S., Farrell, G. C., & George, J. (2004) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2003.03252.x · Cited by 150
Bariatric Surgery as Potential Treatment for Nonalcoholic Fatty Liver Disease: A Future Treatment by Choice or by Chance?
Hafeez, S., & Ahmed, M. H. (2013) · Journal of Obesity · doi:10.1155/2013/839275 · Cited by 150
Patterns of chemotherapy-induced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastases
Khan, A. Z., Morris‐Stiff, G. J., & Makuuchi, M. (2008) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s00534-008-0016-z · Cited by 150
Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease
Trépo, E., Gustot, T., Degré, D., Lemmers, A., Verset, L., Demetter, P., Ouziel, R., Quertinmont, E., Vercruysse, V., Amininejad, L., et al. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.01.028 · Cited by 149
Metabolic and endocrine effects of valproic acid chronic treatment
Belcastro, V., D’Egidio, C., Striano, P., & Verrotti, A. (2013) · Epilepsy Research · doi:10.1016/j.eplepsyres.2013.08.016 · Cited by 149
Genetic determinants of hepatic steatosis in man
Hooper, A. J., Adams, L. A., & Burnett, J. R. (2011) · Journal of Lipid Research · doi:10.1194/jlr.r008896 · Cited by 149
Free fatty acids, not triglycerides, are associated with non-alcoholic liver injury progression in high fat diet induced obese rats
Liu, J., Han, L., Zhu, L., & Yu, Y. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0194-7 · Cited by 149
Variations in ATP-Binding Cassette Transporter Regulation during the Progression of Human Nonalcoholic Fatty Liver Disease
Hardwick, R. N., Fisher, C. D., Canet, M. J., Scheffer, G. L., & Cherrington, N. J. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.041012 · Cited by 148
Shear Wave Dispersion Measures Liver Steatosis
Barry, C. T., Mills, B. N., Hah, Z., Mooney, R. A., Ryan, C., Rubens, D. J., & Parker, K. J. (2011) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2011.10.019 · Cited by 148
Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe
Myers, R. P., Pomier–Layrargues, G., Kirsch, R., Pollett, A. F., Beaton, M. D., Levstik, M. A., Duarte‐Rojo, A., Wong, D., Crotty, P., & Elkashab, M. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.10.007 · Cited by 148
Effects of Omega-3 Polyunsaturated Fatty Acid Supplementation on Non-Alcoholic Fatty Liver: A Systematic Review and Meta-Analysis
Lee, C.-H., Fu, Y., Yang, S., & Chi, C. (2020) · Nutrients · doi:10.3390/nu12092769 · Cited by 148
Nonalcoholic Fatty Liver Disease
Jorgensen, R. A. (2003) · Gastroenterology Nursing · doi:10.1097/00001610-200307000-00003 · Cited by 148
Obesity, Visceral Fat, and NAFLD: Querying the Role of Adipokines in the Progression of Nonalcoholic Fatty Liver Disease
Mirza, M. S. (2011) · ISRN Gastroenterology · doi:10.5402/2011/592404 · Cited by 148
Probiotic mixture VSL# 3: An overview of basic and clinical studies in chronic diseases
Cheng, F.-S., Pan, D., Chang, B., Jiang, M., & Sang, L.-X. (2020) · World Journal of Clinical Cases · doi:10.12998/wjcc.v8.i8.1361 · Cited by 147
Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome
Kargiotis, K. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i25.7860 · Cited by 147
Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo‐controlled trial
McKenzie, J., Fisher, B. M., Jaap, A. J., Stanley, A. J., Paterson, K. R., & Sattar, N. A. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02543.x · Cited by 147
Paraoxonase: A multifaceted biomolecule
Goswami, B., Tayal, D., Gupta, N., & Mallika, V. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.09.025 · Cited by 147
Association Between Variants in or Near PNPLA3, GCKR, and PPP1R3B With Ultrasound-Defined Steatosis Based on Data From the Third National Health and Nutrition Examination Survey
Hernáez, R., McLean, J., Lazo, M., Brancati, F. L., Hirschhorn, J. N., Borecki, I. B., Harris, T. B., Nguyen, T. T., Kamel, I. R., Bonekamp, S., et al. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.02.011 · Cited by 147
Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome
Kim, H. C., Kim, D. J., & Huh, K. B. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.09.012 · Cited by 147
Docosahexaenoic Acid Attenuates Hepatic Inflammation, Oxidative Stress, and Fibrosis without Decreasing Hepatosteatosis in a Ldlr Mouse Model of Western Diet-Induced Nonalcoholic Steatohepatitis
Depner, C. M., Philbrick, K. A., & Jump, D. Β. (2013) · Journal of Nutrition · doi:10.3945/jn.112.171322 · Cited by 147
Adipokines in Nonalcoholic Steatohepatitis: From Pathogenesis to Implications in Diagnosis and Therapy
Tsochatzis, E. A., Papatheodoridis, G., & Archimandritis, A. J. (2009) · Mediators of Inflammation · doi:10.1155/2009/831670 · Cited by 147
Leptin‐mediated neovascularization is a prerequisite for progression of nonalcoholic steatohepatitis in rats†
Kitade, M., Yoshiji, H., Kojima, H., Ikenaka, Y., Noguchi, R., Kaji, K., Yoshii, J., Yanase, K., Namisaki, T., Asada, K., et al. (2006) · Hepatology · doi:10.1002/hep.21338 · Cited by 147
Non‐alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C‐reactive protein in Hispanics
Riquelme, A. J., Arrese, M. A., Soza, A., Morales, A., Baudrand, R. F., Pérez‐Ayuso, R. M., Gonzalez, R. G., Alvarez, M. G., Hernández, V., García‐Zattera, M. J., et al. (2008) · Liver International · doi:10.1111/j.1478-3231.2008.01823.x · Cited by 147
The Early Origins of Obesity and Insulin Resistance: Timing, Programming and Mechanisms
Nicholas, L. M., Morrison, J. L., Rattanatray, L., Zhang, S., Ozanne, S. E., & McMillen, I. C. (2016) · International Journal of Obesity · doi:10.1038/ijo.2015.178 · Cited by 146
Oxidative stress signaling underlying liver disease and hepatoprotective mechanisms
Videla, L. A. (2009) · World Journal of Hepatology · doi:10.4254/wjh.v1.i1.72 · Cited by 146
The first donor death after living-related liver transplantation in Japan
Akabayashi, A., Slingsby, B. T., & Fujita, M. (2004) · Transplantation · doi:10.1097/01.tp.0000115342.98226.7c · Cited by 146
Blood pressure is associated with the presence and severity of nonalcoholic fatty liver disease across the spectrum of cardiometabolic risk
Aneni, E. C., Oni, E., Martin, S. S., Blaha, M. J., Agatston, A. S., Feldman, T., Veledar, E., Conceição, R., Carvalho, J. A. M., Santos, R. D., et al. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000532 · Cited by 146
The modest alcohol consumption reduces the incidence of fatty liver in men: a population‐based large‐scale cohort study
Hashimoto, Y., Hamaguchi, M., Kojima, T., Ohshima, Y., Ohbora, A., Kato, T., Nakamura, N., & Fukui, M. (2014) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12786 · Cited by 146
Dietary Omega-3 Fatty Acid Deficiency and High Fructose Intake in the Development of Metabolic Syndrome, Brain Metabolic Abnormalities, and Non-Alcoholic Fatty Liver Disease
Simopoulos, A. P. (2013) · Nutrients · doi:10.3390/nu5082901 · Cited by 146
Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease
Salvoza, N. C., Klinzing, D. C., Gopez-Cervantes, J. L., & Baclig, M. O. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153497 · Cited by 146
Periodontal disease–related nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: An emerging concept of oral‐liver axis
Kuraji, R., Sekino, S., Kapila, Y. L., & Numabe, Y. (2021) · Periodontology 2000 · doi:10.1111/prd.12387 · Cited by 146
Is weight reduction an effective therapy for nonalcoholic fatty liver?
Wang, R. T., Koretz, R. L., & Yee, H. F. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00449-2 · Cited by 146
Maternal obesity programs offspring nonalcoholic fatty liver disease by innate immune dysfunction in mice
Mouralidarane, A., Soeda, J., Visconti-Pugmire, C., Samuelsson, A.-M., Pombo, J., Maragkoudaki, X., Butt, A., Saraswati, R., Novelli, M., Fusai, G., et al. (2013) · Hepatology · doi:10.1002/hep.26248 · Cited by 145
Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: results from a population-based study
van der Voort, E. A. M., Koehler, E. M., Dowlatshahi, E. A., Hofman, A., Stricker, B. H., Janssen, H. L. A., Schouten, J. N. L., & Nijsten, T. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.10.044 · Cited by 145
Influence of ethnicity on histological differences in non-alcoholic fatty liver disease
Mohanty, S. R., Troy, T. N., Huo, D., O'Brien, B., Jensen, D. M., & Hart, J. A. L. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.11.017 · Cited by 145
Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome
Vassilatou, E., Lafoyianni, S., Vryonidou, A., Ioannidis, D., Kosma, L. K., Katsoulis, K., Papavassiliou, E. D., & Tzavara, I. (2009) · Human Reproduction · doi:10.1093/humrep/dep380 · Cited by 145
‘Endocrine NAFLD’ a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis
Lonardo, A., Carani, C., Carulli, N., & Loria, P. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.03.005 · Cited by 145
Pathologic features associated with fibrosis in nonalcoholic fatty liver disease
Gramlich, T. L., Kleiner, D. E., McCullough, A. J., Matteoni, C. A., Boparai, N., & Younossi, Z. M. (2004) · Human Pathology · doi:10.1016/j.humpath.2003.09.018 · Cited by 145
Enhanced expression of pro-inflammatory mediators and liver X-receptor-regulated lipogenic genes in non-alcoholic fatty liver disease and hepatitis C
Lima-Cabello, E., García-Mediavilla, M. V., Miquilena-Colina, M. E., Vargas-Castrillón, J., Lozano-Rodríguez, T., Fernández-Bermejo, M., Olcoz, J. L., González-Gallego, J., García-Monzón, C., & Sánchez-Campos, S. (2011) · Clinical Science · doi:10.1042/cs20100387 · Cited by 144
Progression of Alcoholic and Non-alcoholic Steatohepatitis: Common Metabolic Aspects of Innate Immune System and Oxidative Stress
Sakaguchi, S., Takahashi, S., Sasaki, T., Kumagai, T., & Nagata, K. (2010) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-10-rv-087 · Cited by 144
Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal
Schmitt, J., Kong, B., Stieger, B., Tschopp, O., Schultze, S. M., Rau, M., Weber, A., Müllhaupt, B., Guo, G. L., & Geier, A. (2014) · Liver International · doi:10.1111/liv.12456 · Cited by 144
The Role of Lipid and Lipoprotein Metabolism in Non‐Alcoholic Fatty Liver Disease
Perla, F. M., Prelati, M., Lavorato, M., Visicchio, D., & Anania, C. (2017) · Children · doi:10.3390/children4060046 · Cited by 144
Effect of miRNA‐10b in regulating cellular steatosis level by targeting PPAR‐α expression, a novel mechanism for the pathogenesis of NAFLD
Zheng, L., Lv, G., Sheng, J., & Yang, Y. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05949.x · Cited by 143
Platelet count for predicting fibrosis in nonalcoholic fatty liver disease
Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD), Yoneda, M., Fujii, H., Sumida, Y., Hyogo, H., Itoh, Y., Ono, M., Eguchi, Y., Suzuki, Y., Aoki, N., et al. (2011) · Journal of Gastroenterology · doi:10.1007/s00535-011-0436-4 · Cited by 143
Caffeine is protective in patients with non‐alcoholic fatty liver disease
Birerdinc, A., Stepanova, M., Pawloski, L. R., & Younossi, Z. M. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04916.x · Cited by 143

Authors: Angulo, P.
Affiliations: Mayo Clinic (US)
Corresponding author: Angulo, Paul
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2002-04-18
Volume: 346
Issue: 16
Pages: 1221-1231
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmra011775
OpenAlex: W2040109162
Cited by: 5,228
References: 90
Citations by year: 2026: 38 · 2025: 80 · 2024: 102 · 2023: 171 · 2022: 155 · 2021: 191 · 2020: 246 · 2019: 228 · 2018: 222 · 2017: 264 · 2016: 275 · 2015: 339 · 2014: 368 · 2013: 319 · 2012: 309
FWCI: 23.15
Type: journal article
Language: en
Open access: closed
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords: non-alcoholic fatty liver disease, hepatic steatosis, steatohepatitis, liver fibrosis, liver cirrhosis, obesity, type 2 diabetes, hyperlipidemia, risk factors, alcohol abuse
MeSH terms: Biopsy, Fatty Liver, Humans, Liver, Liver Function Tests, Radiography, Risk Factors, Ultrasonography, Weight Loss, Prevalence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Nonalcoholic Fatty Liver Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks